NHSX announced Digital Health Partnership Award first phase winners

25

Oct 2021

On September 29, 2021, NHSX announced phase-one winners of a Digital Health Partnership Award. Applications were submitted by NHS organizations in July 2021. The Award will help NHS organizations receive funding to accelerate the adoption of digital health products and services to monitor patients with long-term conditions remotely. There will be three categories of funding: projects requiring the support of up to £100,000, £250,000, and £500,000.

Fourteen projects have been awarded in the first phase. Some examples are provided below:

  • Respiratory remote monitoring program: will utilize existing virtual consultation technology in conjunction with a new asynchronous remote patient monitoring platform;
  • MSK (Musculoskeletal) care pathway;
  • Evidence-based scaling of virtual wards: an expansion of the virtual ward project (built on the innovative digital-first model of oximitry@home) to include a COPD;
  • Cardiac rehabilitation services: will provide patients who require Phase 3 cardiac rehabilitation services through remote monitoring. The project will also offer a range of devices such as blood pressure and pulse oximeter;
  • Self-care and remote monitoring support in Primary Care;
  • Chronic obstructive pulmonary disease (COPD) management;
  • Secure video sharing platform: it enables sharing seizure videos for remote clinical interpretation and management advice. An expansion of this service is planned to include the wider neurology service and the movement disorder service and will support children with complex epilepsy;
  • Supporting children with type 2 diabetes.

The second phase of the Award is opening for bids in November 2021.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more